Lifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth
NCT07095010 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224
Last updated 2025-08-01
Summary
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common cause of chronic liver disease in children and adolescents. Lifestyle factors are modifiable risk factors that may play a key role in both the prevention and management of the disease. However, existing data on the association between lifestyle and MASLD in pediatric populations are limited and often focus on isolated aspects such as diet or physical activity, with little attention given to other parameters like sleep habits. The aim of the present study is to comprehensively investigate the association between lifestyle factors, including dietary habits, physical activity, sedentary activities, and sleep habits, and the presence of MASLD in a sample of 224 children and adolescents with overweight or obesity. The study will include newly diagnosed MASLD patients compared to matched controls without the disease. A wide range of assessments will be conducted, including anthropometric measurements, body composition analysis, liver elastography, biochemical testing, and standardized lifestyle questionnaires. This study seeks to fill important research gaps and explore potential associations between lifestyle habits and pathophysiological markers involved in the onset and progression of MASLD.
Conditions
- Metabolic Dysfunction-Associated Steatotic Liver Disease
- Childhood Obesity
Sponsors & Collaborators
-
Children 's Hospital, Agia Sophia
collaborator UNKNOWN -
Harokopio University
lead OTHER
Principal Investigators
-
Meropi D Kontogianni · Harokopio University Athens, Kallithea, Greece
Eligibility
- Min Age
- 10 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-10
- Primary Completion
- 2024-10-31
- Completion
- 2024-12-20
Countries
- Greece
Study Locations
More Related Trials
-
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
NCT04454463 ·Status: COMPLETED
-
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 ·Status: UNKNOWN ·Phase: NA
-
Nonalcoholic Steatohepatitis in Chinese Children
NCT03190538 ·Status: RECRUITING
-
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
NCT06536933 ·Status: NOT_YET_RECRUITING
-
DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD
NCT07249112 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
NCT06495333 ·Status: RECRUITING
-
Hepatic Elastography-Enhanced Lifestyle Modification in MASLD
NCT06826807 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity
NCT06446908 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
NCT07188220 ·Status: RECRUITING
-
Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD
NCT07313007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
NCT06986447 ·Status: ENROLLING_BY_INVITATION
-
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
NCT02217345 ·Status: COMPLETED ·Phase: PHASE2
-
Mastiha Treatment for Obese With NAFLD Diagnosis
NCT03135873 ·Status: COMPLETED ·Phase: NA
-
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07013916 ·Status: RECRUITING ·Phase: NA
-
Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children
NCT05073588 ·Status: COMPLETED ·Phase: NA
-
Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07199491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Advanced Fibrosis Detection for MASLD in Primary Care
NCT07159386 ·Status: RECRUITING ·Phase: NA
-
Risk of MASLD in Adults in Romania
NCT06864845 ·Status: COMPLETED
-
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ketogenic Diet in MASLD-related cACLD
NCT06537466 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients
NCT06503068 ·Status: RECRUITING
-
GLP-1 RA on Liver OMICS in MASLD
NCT06982378 ·Status: NOT_YET_RECRUITING
-
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
NCT06342947 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Losartan in the Treatment of NAFLD in Children
NCT01913470 ·Status: COMPLETED ·Phase: PHASE2
-
Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes
NCT07270822 ·Status: NOT_YET_RECRUITING ·Phase: NA